Analysis | Metabolite Name | Measured Value | Units | Construct |
---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 20866 | Peak area | Noxa knockdown |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 22555 | Peak area | Noxa knockdown |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 23791 | Peak area | Noxa knockdown |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 26342 | Peak area | Control lentivirus |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 28057 | Peak area | Control lentivirus |
Reversed phase NEGATIVE ION MODE | LEUCINE (CAS# 328-39-2); (M-H)- | 31149 | Peak area | Control lentivirus |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 13400000 | Peak area | Control lentivirus |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 14600000 | Peak area | Control lentivirus |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 14800000 | Peak area | Noxa knockdown |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 14900000 | Peak area | Noxa knockdown |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+H)+ | 15500000 | Peak area | Control lentivirus |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 82937 | Peak area | Noxa knockdown |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 85641 | Peak area | Noxa knockdown |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 88087 | Peak area | Noxa knockdown |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 98646 | Peak area | Control lentivirus |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 104507 | Peak area | Control lentivirus |
Reversed phase POSITIVE ION MODE | LEUCINE (CAS# 328-39-2); (M+NA)+ | 105189 | Peak area | Control lentivirus |